Source: Annual Congress 2001 - Assessment of risk factors for severe childhood asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Eboriadou, K. Haidopoulou, M. Hatzistilianou, M. Tsiligiri, A. Petridou, V. Mougios, S. Karamperis (Thessaloniki, Greece). Plasma fatty acids in asthmatic children of Northern Greece. Eur Respir J 2001; 16: Suppl. 31, 3025

Member's Comments

No comment yet.

Related content which might interest you: Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007 Food and fatty acid intake and atopic disease in adults Source: Eur Respir J 2004; 23: 575-582 Year: 2004 Polyunsaturated fatty acids in maternal diet and maternal and cord blood in relation to atopic dermatitis in children Source: Eur Respir J 2004; 24: Suppl. 48, 161s Year: 2004 The n-3 long chain polyunsaturated fatty acids (n-3LCPUFA) are inversely linked to asthma and persistent symptoms of allergy in children born to mothers with allergy Source: Eur Respir J 2006; 28: Suppl. 50, 251s Year: 2006 Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007 Association between Ω3 and Ω6 fatty acid dietary intakes and serum inflammatory markers in Spanish COPD patients Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010 Oral polyunsaturated fatty acid supplementation as adjuvant therapy for asthmatic children Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Plasma amino acid profiles in patients of various respiratory disorders Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Intake of n-3 polyunsaturated fatty acids in childhood, FADS genotype and incident asthma Source: Eur Respir J, 58 (3) 2003633; 10.1183/13993003.03633-2020 Year: 2021 Amino acids and asthma: a case-control study Source: Eur Respir J 2004; 23: 565-568 Year: 2004 Blood plasma levels of ascorbic acid in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006 Supplementation with n-3 fatty acids and markers of oxidative stress in elderly exposed to PM2.5 Source: Eur Respir J 2007; 30: Suppl. 51, 630s Year: 2007 Serum uric acid levels among COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 435s Year: 2003 Effects of long-term supplementation of branched-chain amino acids on muscle metabolism in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 638s Year: 2006 Polyunsaturated fatty acids, lactobacillus bifidus, vitamin A and D in the treatment of IgA immunodeficiency in children with frequent respiratory infections Source: Eur Respir J 2004; 24: Suppl. 48, 357s Year: 2004 Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis Source: Eur Respir J 2007; 29: 958-964 Year: 2007 Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon? Source: Eur Respir J, 58 (3) 2101386; 10.1183/13993003.01386-2021 Year: 2021 Serum uric acid levels among patients with COPD exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006 Prenatal exposure to n-6/n-3 fatty acids, trace elements and minerals and risk of atopic disease in childhood: birth cohort study Source: Eur Respir J 2003; 22: Suppl. 45, 564s Year: 2003 Late Breaking Abstract: Prenatal n-3, n-6, and trans fatty acids and the risk of eosinophilia and allergic sensitization in children at age 3 years Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring Year: 2010